Hydromorphone dosing changes during ECMO
Treatments studied
Part of Heart & circulation, Lungs & breathing clinical trials.
This Phase 2 study looks at how hydromorphone (a strong pain medicine) behaves in the body for people on ECMO, and how that may affect dosing. It may help doctors better choose the right pain-med dose while someone is receiving ECMO.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are currently taking hydromorphone for pain relief.
- You have been on ECMO for more than 96 hours.
- You do not have an allergy to hydromorphone.
- You should not be pregnant and must be able to sign consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a structured approach to managing pain and sedation medications in patients on ECMO (a machine that does the work of the heart and lungs). Researchers want to see if following a clear protocol makes this care safer and more effective.
This study looks at how well the ECMO machine works in high-altitude areas. It tests the oxygen exchange in the machine to help improve care for patients at high elevations.
This trial is studying whether using less of the medicines that raise blood pressure (vasopressors) can help people with severe heart failure who are on a heart-lung machine (ECMO) survive. It may answer if a gentler approach is safer.
This study measures how sedating and pain medicines move through the body in children who are supported by ECMO (a heart-lung machine). It may help doctors choose safer and more effective dosing for sedation and pain control during ECMO.
This study tests a pain medicine called hydromorphone for people in the ICU who need a breathing tube. The goal is to see how well it works and if it's safe for managing pain and sedation.
This trial tests a quick-acting pain medicine (hydromorphone) given through a vein to treat severe chest pain. It may be an option for people experiencing acute pain who haven't been helped by other medicines.
Hear when a new Extracorporeal Membrane Oxygenation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.